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Abstract
Background: A. fumigatus has been associated with a wide spectrum of allergic disorders such as ABPA or SAFS. It
is poorly understood what allergens in particular are being expressed during fungal invasion and which are
responsible for stimulation of immune responses. Study of the dynamics of allergen production by fungi may lead
to insights into how allergens are presented to the immune system.
Methods: Expression of 17 A. fumigatus allergen genes was examined in response to various culture conditions
and stimuli as well as in the presence of macrophages in order to mimic conditions encountered in the lung.
Results: Expression of 14/17 allergen genes was strongly induced by oxidative stress caused by hydrogen peroxide
(Asp f 1, -2, -4, -5, -6, -7, -8, -10, -13, -17 and -18, all >10-fold and Asp f 11, -12, and -22, 5-10-fold) and 16/17
allergen genes were repressed in the presence of cAMP. The 4 protease allergen genes (Asp f -5, -10, -13 and -18)
were expressed at very low levels compared to the comparator (b-tubulin) under all other conditions examined.
Mild heat shock, anoxia, lipid and presence of macrophages did not result in coordinated changes in allergen gene
expression. Growth on lipid as sole carbon source contributed to the moderate induction of most of the allergen
genes. Heat shock (37°C > 42°C) caused moderate repression in 11/17 genes (Asp f 1, -2, -4, -5, -6, -9, -10, -13, -17,
-18 and -23) (2- to 9-fold), which was mostly evident for Asp f 1 and -9 (~9-fold). Anaerobic stress led to moderate
induction of 13/17 genes (1.1 to 4-fold) with one, Asp f 8 induced over 10-fold when grown under mineral oil.
Complex changes were seen in gene expression during co-culture of A. fumigatus with macrophages.
Conclusions: Remarkable coordination of allergen gene expression in response to a specific condition (oxidative
stress or the presence of cAMP) has been observed, implying that a single biological stimulus may play a role in
allergen gene regulation. Interdiction of a putative allergen expression induction signalling pathway might provide
a novel therapy for treatment of fungal allergy.
Introduction
Allergy is becoming one of the most common ailments
in the developed world [1,2]. This condition arises from
disproportionate IgE-mediated and/or eosinophilic
responses of the immune system to contact with an
antigen [3]. Such antigens are usually proteins and are
termed allergens. The characteristics of allergens that
make them allergenic are not well understood but it is
considered likely that such proteins must be stable and
resistant to proteases or that they possess cryptic struc-
tural features that are particularly provocative to the
immune system [4,5]. A significant proportion of allergy
is caused by fungal proteins [6]. In contrast to other
more common environmental allergens such as those
from dust mite faeces, pollen or pet dander, fungal aller-
gens are likely to be dynamically expressed by the fun-
gus during transient or long-term colonization of the
airways and other mucosal surfaces. Study of the timing
and context of gene expression may therefore lead to
insights into important events in the early interaction
between the immune system and the allergenic protein.
In particular, the timing and level of allergen expression
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may possibly be involved in determining that the protein
is an allergen by determining when the protein comes
into contact with the immune system for example after
macrophage phagocytosis or during interaction with
neutrophils or eosinophils. The most common route of
exposure to fungi is via the respiratory tract [7-10]
although some fungi that produce allergens are also der-
matophytes [11]. In the scenario where allergen gene
expression is critical to allergenicity of the expressed
protein, allergen genes may be expressed constitutively
at high levels. Alternatively several possible conditions
may be encountered in the lung that may trigger high
levels of allergen gene expression. These conditions
might be expected to include presence of lung surfac-
tant lipid as a carbon source, anaerobic growth in
regions of the lung blocked off by mucus plugs, oxida-
tive stress during phagocytosis, heat shock from inflam-
matory responses or the presence of immune cells such
as macrophages [12-16]. Aspergillus fumigatus is well
studied as an invasive pathogen of humans [17-19] but
is also a major source of fungal allergens involved in
allergy and exacerbations of asthma such as Severe
Asthma with Fungal Sensitisation (SAFS) and Allergic
Bronchopulmonary Aspergillosis (ABPA) [20-23]. The
demonstration of coordinated regulation of allergen
expression would suggest a possible new therapeutic
avenue based in interdiction of a common transcrip-
tional activation mechanism during colonisation. How-
ever, few detailed studies on allergen expression have
yet been performed. We recently refined the gene struc-
ture and classification of the A. fumigatus allergens
[24,25]. Here we have developed Real-Time PCR expres-
sion assays for 17 A. fumigatus allergen genes (Asp f 1-
12, -13, -17, -18, -22 and -23) and tested various defined
conditions that might trigger expression (recent A. fumi-
gatus allergen gene nomenclature and their identities are
presented in [25]).
Methods
A. fumigatus strain, media and growth conditions
In order to test what conditions trigger the expression
of A. fumigatus allergen genes, the fungus was grown in
various culture media chosen to mimic the conditions
encountered in the lung. Af293 [26] cultures were
grown in 200 ml Sabouraud dextrose broth (SB) for
24 h at 37°C with agitation (200 rpm), washed 3 times
in Aspergillus minimal medium [27] (AMM) and used
to inoculate parallel duplicate 50 ml cultures of AMM
containing either (i) 1% glucose, (ii) 0.5% phoshotidyl
choline, (iii) 1% glucose + 1.8 mM hydrogen peroxide,
(iv) 1% glucose + 5 mM menadione and (v) 1% glucose
+ 5 mM diamide. Concentrations of peroxide, mena-
dione and diamide (Sigma-Aldrich) were chosen to
allow >95% normal growth. Other conditions included
(vi) a static AMM + 1% glucose culture, degassed under
vacuum for 5 minutes then overlaid with 50 ml mineral
oil to create anoxic conditions (changing oxygen tension
from 140 mm Hg to 14 mm Hg), (vii) AMM + 1% glu-
cose culture grown at 42°C, (viii) AMM + 1 mM dibu-
tyryl cyclic adenosine monophosphate (dbtcAMP)
(Sigma-Aldrich), (ix) AMM only and (ix) SB culture.
Subsequently, all cultures were grown with agitation
(200 rpm) (except condition vi) for 24 h at 37°C (except
condition vii) and approximately 2 ml of each sample
was collected after 3 h, 6 h, 9 h and 24 h for RNA
extraction.
Generation of macrophages from peripheral blood
mononucleocytes and co-culture with A. fumigatus
Since macrophages are one of the first immune cells
that come in contact with a pathogen in the respiratory
tract [28], allergen gene expression was also tested after
challenge of A. fumigatus with blood monocyte derived
macrophages. Blood was obtained from healthy volun-
teers (Wythenshawe Hospital, Manchester, UK) and
layered over 10 ml Ficoll using a Pasteur pipette in 50
ml sterile tubes. The tubes were centrifuged for 20 min
at 800 × g at room temperature in a swinging bucket
rotor centrifuge and the buffy coat layer containing
monocytes and lymphocytes was removed, and trans-
ferred to a new sterile tube. The cells were washed once
with Dulbecco’s Phosphate Buffered Saline (PBS)
(Sigma-Aldrich) and centrifuged for 7 min at 800 × g at
room temperature. The pellet was subsequently washed
twice in Dulbecco’s PBS and centrifuged for 7 min at
400 × g at room temperature. The cells were resus-
pended in 5 ml of RPMI 1640-L-glutamine containing
10% Foetal Bovine Serum, 100 U/ml penicillin and 0.1
mg/ml streptomycin, and counted under a haemocyt-
ometer (diluted 1:1 with trypan blue (Sigma-Aldrich) for
viable count). Macrophages were induced by growth for
10-12 days with addition of 4 ng/ml recombinant
human granulocyte-macrophage colony stimulating fac-
tor (hGM-CSF). Following the incubation, macrophages
were counted and Af293 spores were added to the cul-
tures at two different concentrations denoted here as
multiplicities of infection (MOI) - 1:200 and 1:2000
spores/macrophage. The fungus was allowed to grow for
24 h or 48 h before hyphae/macrophage samples were
collected for RNA extraction. Cultures that had not
been inoculated with fungus (macrophage only and
RPMI-FBS-PS only) were used as controls.
Preparation of RNA
Three aliquots consisting of 2 ml of each culture grown
in various media and 200 μl of A. fumigatus/macro-
phage cultures were harvested at various time points
and used to prepare RNA. RNA was extracted using the
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FastRNA Pro Red Kit (MPBio) according to the manu-
facturer’s instruction followed by treatment with RQ1
RNase-Free DNase (Promega) and ethanol precipitation.
RNA was subsequently quantified by spectrometry.
Quantitative PCR (qRT-PCR)
All reactions were performed in a Stratagene Mx3005p
qRT-PCR machine. Primer concentrations were inde-
pendently optimized to favour product formation then
amplification efficiency for each optimised primer pair
was calculated using a 2-fold dilution series. Twenty five
microliter reactions containing 12.5 μl Brilliant II SYBR
Green QRT-PCR Mix (Stratagene), RT (Reverse Tran-
scriptase)/RNase block enzyme mixture, intron spanning
primers (Table 1) and 100 ng total RNA were cycled at
50°C for 1 h followed by 40 cycles of 94°C for 30 sec,
55°C for 30 sec and 72°C for 60 sec. Fluorescence was
read at 55°C three times during each cycle. Melting
curves were subsequently determined for each reaction
to ensure that single products were produced and the
resulting reaction was run on a 1.8% agarose gel to con-
firm the product was unique and of the correct size.
Triplicate or quadruplicate RNA preps from three repli-
cate growth conditions were subjected to qRT-PCR. No
RNA and no RT controls were also included. RNA
quantitation was then performed according to the
2ΔΔCt method [29]. Allergen qRT-PCR results were
normalised against the b-tubulin gene and compared to
the expression of the same allergen gene in control con-
ditions. Results are presented as mean values in a histo-
fram with standard errors calculated using GraphPad
PRISM 4.0 and significant differences were assessed
pairwise using students T-tests with P values <0.05
representing significance.
Results
Selection of a standard comparator gene and validation
of qRT-PCR
Actin, b-tubulin, glucan synthetase subunit 1 (Fks1) and
glyceraldehyde 3 phosphate dehydrogenase (GpdA) were
assessed as controls to normalize expression (accession
numbers and the primers are presented in Table 1).
cDNA fragments of each gene were isolated by PCR
using the primers described then quantified by compari-
son with known standards on agarose gels and by spec-
trophotometry. Ten pMol of each cDNA product was
used as a comparator against 100 ng total cell RNA to
estimate relative RNA levels for each gene under the
growth conditions described although direct quantitative
comparison between product level from an qRT-PCR
Table 1 Intron spanning primers used in the expression analysis
Gene CADRE Forward pMol Reverse pMol
Asp f 1 AFUA_5G02330 ACGCTCGTGCG*ACCTGGACATGC 40 GCCGTCGGAAAGAGGTGCGTG 20
Asp f 2 AFUA_4G09580 CTGTGCTTTGGAAG*GCTGGGGCGGCCAC 40 GTCTCCATGTGCTCCCAGGGC 40
Asp f 3 AFUA_6G02280 GGGACGACATT*CTCTTCCTCTCCGAC 40 CGCTCGAGAACTCGAGGTGGTTC 40
Asp f 4 AFUA_2G03830 CAGCTCTTCCCACTCCGACAG 40 CTGGGTTCGGTCCTGCCAC 40
Asp f 5 AFUA_8G07080 TACTCACGGTC*TTTCCAACCGAC 40 GCTTCAGACGGATGGCCGTC 40
Asp f 6 AFUA_1G14550 ACTACCTTCAG*TACTTGAACGAC 100 GTACACGTTCATGAATGGGTG 40
Asp f 7 AFUA_4G06670 GCTCCTATCTTCAAGTCCCT 40 CCACACTACGTCCACTTCAC 40
Asp f 8 AFUA_2G10100 ACCTCCAGGAGCTCATCGCCGAG 20 CTCCTCCTTCTTCTCCTCAG 40
Asp f 9 AFUA_1G16190 GAGGTTGACTGG*GAAGTATTG 40 GAAAGTCTCCTGAGGAGTG 10
Asp f 10 AFUA_5G13300 GCGGCATTGCTG*ACACCGGC 40 GCAGGGGAAGACATAACCACCG 40
Asp f 11 AFUA_2G03720 GGTCCTAACAC*CAACGGC 40 GAGCTTCGATCTCCTTGAC 40
Asp f 12 AFUA_5G04170 TGACCAAGGCT*GATTTGATC 40 CAACAAGGTAAGCAGAGTAG 40
Asp f 13 AFUA_4G11800 GAGCGCAGAC*GTTGCCCATG 40 CCTTGTGGGAAATGCTGCCCAG 40
Asp f 17 AFUA_4G03240 ACCATCAACTCCGGTGTCGAC 10 CTTGGAGATGAGGTCGTCG 40
Asp f 18 AFUA_5G09210 CTCCCAAC*CTCCTTGCCTG 40 CTCGGCCTTGTGAACTAG 40
Asp f 22 AFUA_6G06770 CATGATCGTCCCTGA*CTCCGC 40 CACCCTCGTCACCAACGTTG 40
Asp f 23 AFUA_2G11850 GCAGATTACTCC*CATGGGTG 40 GTACAGGGTCTTGCGCAG 40
Actin AFUA_6G04740 TCATCATGCGCGACAGC 10 CAATCATGATA*CCATGGTGAC 40
b-tubulin AFUA_1G10910 CGACAACGAG*GCTCTGTACG 40 CAACTTGCGCAGATCAGAGTTGAG 40
GpdA AFUA_5G01970 GGCGAGCTCAAGAACATCCTCGGCTA 20 CTTGGCGATGTAGGCGATAAGGTCGA 20
FksA AFUA_6G12400 GCTGCGCCCAAG*TCGCCAAATC 40 GAACAACAAGTGGGGCAATG 20
As part of the initial work up for these experiments primer concentrations were optimized so that all allergens could be analysed using a single annealing
temperature in the PCR. Primer levels used are indicated. Primers used to establish the most useful comparator are also included.
pMol = pMol primer used per 25 μl reaction mix; * - intron site.
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reaction and a simple PCR reaction was deemed inap-
propriate. Actin, b-tubulin and Fks1 provided good con-
stitutive controls whereas GpdA was observed to vary
considerably in its expression level (Figure 1). As b-tubu-
lin appeared to show a useful constitutive level of expres-
sion it was used as a standard in subsequent experiments
although the actin and Fks1 genes were occasionally used
as a “quis custodiet” control to confirm levels of the con-
trol comparator. Dissociate curves of qRT-PCR amplified
products calculated by plotting the negative derivative of
fluorescence [-R´(T)] emitted by the PCR sample during
the melting procedure (from 52°C to 95°C) showed a sin-
gle melting peak with melting temperature (Tm) of 75°C
or higher indicating specific qRT-PCR product. More-
over, agarose gel electrophoresis of these products con-
firmed amplification of a single product for each allergen
gene from mRNA and no primer-dimer formation were
generated during the qRT-PCR reactions. Control reac-
tions (no RNA and no RT) did not generate any products
and no dissociation curves for them were observed (data
not shown).
Relative expression of allergen genes
In order to test whether allergens are all expressed at
high level, relative allergen expression level during
growth on AMM containing 1% glucose was determined
(Figure 2A). Some allergens, Asp f 3, -7, -8, -22 and -23,
showed relatively high level of expression whilst others,
notably the proteases Asp f 5, -10, -13 and -18, showed
low levels of expression. This basal level expression was
used in subsequent experiments to determine whether
certain stimuli induced or repressed expression relative
to this defined condition.
Allergen gene expression in response to oxidative stress
The expression of 17 A. fumigatus allergen genes was
analysed upon fungal growth in various in vitro experi-
mental media, chosen to mimic conditions in the lung.
Figure 1 Relative expression of candidate comparator genes in relation to known standards. Each gene shown was tested by qRT-PCR
on 100 ng RNA from the conditions shown. A 10 pM DNA comparator from the cognate gene was used to estimate relative expression level.
Standard errors from triplicate experiments are shown. SB, Sabouraud Broth; AMM, Aspergillus minimal medium; +G, +1% glucose; +H, +1.8 mM
hydrogen peroxide; +M, +5 mM menadione; +D, +5 mM diamide; +L, +1% phoshotidyl choline; 42, culture grown at 42°C; -O2, culture grown in
anoxic conditions. Error bars represent standard error of mean of biological replicates calculated using GraphPad PRISM 4.0.
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Figure 2 Expression levels of allergen genes in the presence of different culture conditions. A, expression levels of all allergens relative to
a b-tubulin comparator during growth on AMM + 1% glucose showing detail of the low expression levels of Asp f 5, -6, -9, -10, -13 and -18
(same data as left panel). B, Expression levels of allergen genes in the presence of various oxidative stress inducing agents. Levels are shown on
a log scale as expression relative to that observed without addition of oxidative stress inducing agents (AMM + 1% glucose, as shown in panel
A). C, Expression levels of allergen genes under different growth conditions. Levels are shown on a log scale as expression relative to that
observed without addition of oxidative stress inducing agents (AMM + 1% glucose, as shown in panel A). Error bars represent standard error of
mean of biological replicates calculated using GraphPad PRISM 4.0.
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As exposure to oxidative stress is reportedly one of the
earliest events in fungus host interaction we tested aller-
gen expression in response to hydrogen peroxide, which
we expect would be directly encountered by the fungus
and menadione and diamide, which alter the internal
redox state of the cell [30].
Eleven allergen genes (Asp f 1, -2, -4, -5, -6, -7, -8,
-10, -13, -17 and -18) were induced >10 fold compared
with control (AMM + 1% glucose) during growth on
hydrogen peroxide but not other sources of oxidative
stress such as menadione or diamide (Figure 2B). Those
allergens include enzymes (among others all 4 tested A.
fumigatus proteases) and 4 proteins of unknown to date
functions (Asp f 2, -4, -7 and -17). Asp f 11, -12 and -22
were induced 5-10 fold under the same conditions.
Expression of Asp f 3 (peroxiredoxin) and Asp f 23
(ribosomal L3 protein) was relatively unchanged during
growth on hydrogen peroxide. Only one allergen gene,
Asp f 9 was repressed under this condition. Thus, the
expression of 14/17 allergen genes was induced under a
single condition suggesting the possibility of coordinated
regulation of allergen gene expression. This type of oxi-
dative stress is similar to that encountered by germinat-
ing fungal spores that are engulfed by macrophages with
the timing of expression being consistent with reports of
the lifespan of engulfed fungal spores [31,32].
Agents that alter intracellular redox balance might be
expected to reproduce the effects of exogenous hydro-
gen peroxide as this is likely to be processed via dismu-
tases and catalases to release intermediates that cause
oxidative stress. Alternatively, hydrogen peroxide may
play a role in signalling or other cellular processes that
is more relevant to the observed allergen induction than
simple oxidative damage. Menadione generates superox-
ide anions (O2
·-) which interact with iron-sulphur clus-
ters in proteins generating hydroxyl radical (OH·).
Diamide, a thiol-oxidizing agent, results in GSH/GSSG
redox imbalance in the cell [30]. Neither compound sti-
mulated the significant induction of allergen genes. On
the contrary, 10 genes (Asp f 2, -4, -5, -6, -7, -9, -10,
-13, -18 and -23) were repressed during growth on
menadione with only one (Asp f 8 coding for ribosomal
P2 protein) induced over 10-fold. Diamide marginally
increased the expression of most allergen genes (except
Asp f 8 and -23), ranging from ~1.1 to ~3 fold. Only
Asp f 4, -5 and -10 were induced more than 3-fold,
compared to AMM + 1% glucose (Figure 2B).
Allergen gene expression in response to complex media,
lipid, heat shock and anaerobic conditions
Conditions such as anoxia, mild heat shock (42°C) and
lipid (phoshotidyl choline) are expected to be encoun-
tered by fungi during entry into or colonization of the
lung. Here we tested allergen expression levels in
response to transfer to media containing these compo-
nents or growth under these conditions. Samples were
analysed at 3 h, 6 h, 9 h and 24 h but only the 9 h time
point is presented in Figure 2C for clarity and because
little variation in expression was observed between the
time points analysed. None of the conditions tested
resulted in coordinated high levels of expression or
repression of the allergen genes.
Transfer of mycelium from AMM + 1% glucose to
complex medium (Sabouraud Broth) caused repression
of 12/17 genes tested, except Asp f 3, -6, -7, -8 and -22,
however the induction of these genes was not substan-
tial (~1.1 to 3-fold). Seven out of these genes (Asp f 1,
-2, -4, -5, -10, -13 and -17) were strongly repressed
(over 10-fold) under this condition.
Asp f 5, -6 and -9 were the only genes repressed
(4, ~1.1 and ~2 fold, respectively) when grown under
mineral oil (anaerobic stress). Asp f 8 was induced over
10-fold and the induction of other genes ranged from
1.5- (Asp f 2) to 5-fold (Asp f 12) under the same condi-
tion. Heat shock (42°C) caused moderate repression in
11/17 genes tested (Asp f 1, -2, -4, -5, -6, -9, -10, -13,
-17, -18 and -23) with the most evident for Asp f 1 and
9 (~9-fold). Other 6 genes (Asp f 3, -7, -8, -11, -12 and
-22) we induced from between 1.5- (Asp f 3) to 5-fold
(Asp f 8). Growth on lipid as sole carbon source con-
tributed to the moderate induction of most of the aller-
gen genes. Only Asp f 5 was slightly repressed under
this condition (~3 fold).
Allergen gene expression in response to dibutyryl cyclic
AMP
Cyclic AMP is a good candidate signal for control of
disparate sets of genes as it acts widely on gene expres-
sion in the cell. Allergen qRT-PCR results obtained
from the cultures grown in presence of the membrane
permeable cAMP analogue dibutyryl cAMP (dbtcAMP)
[33] were normalised against the housekeeping gene (b-
tubulin) and compared to the expression of the same
normalised gene in the -dbtcAMP medium after both 6
h and 24 h. Sixteen out of 17 allergen genes tested were
significantly repressed in the presence of the dbtcAMP
(Figure 3). Only Asp f 23 was induced in the presence
of this compound after both 6 h and 24 h. Its expression
was higher for both conditions than for b-tubulin.
Response of allergen expression to macrophages
In order to determine whether the coordinated
responses observed in axenic culture could be replicated
by co-cultivation of A. fumigatus with macrophages,
expression levels were determined at two different MOI
- 1:200 and 1:2000 spores/macrophage. The MOI used
were chosen to give conditions where both fungus and
macrophage were able to grow and remain viable for
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the duration of the experiment. Lower MOI (< 1:2000)
resulted in complete suppression of the fungus by the
macrophages and higher MOI (> 1:200) resulted in
rapid overgrowth of the culture with fungus and death
of the macrophages after 48 h. To ensure viability, cul-
tures and co-cultures were stained with vital dyes at
points throughout the experiment. Microscopic analysis
revealed that the macrophages were active and appeared
to be aggressively attacking fungal spores throughout.
Insufficient RNA was obtained from earlier time points
(0 h, 6 h and 12 h) to achieve reproducible results (data
not shown) and therefore samples were only analysed
after 24 h and 48 h of incubation. The growth form of
the fungus was predominantly hyphal at 24 h (> 95%
with fewer than 5% spores and germlings remaining).
The Aspergillus/macrophage qRT-PCR results were
normalised against the b-tubulin gene and compared to
the normalised results obtained from control conditions
(Aspergillus only) after 24 h and 48 h.
The response of allergen expression upon incubation
with macrophages is complex and clearly lacks the coor-
dinated nature of the responses observed in axenic cul-
ture (Figure 4). The 4 protease allergens, Asp f 5, -10
and -13 and -18 were expressed at very low levels and
did not appear to increase expression in the presence of
macrophages. The allergen gene expression was strongly
affected by the MOI; Asp f 2, -6 and -13 are all strongly
expressed at the higher MOI of 1 spore per 200 macro-
phages but expressed at very low levels at an MOI of
1:2000. In general effects of co-culture age or MOI
affected expression whereas presence or absence of
macrophages did not alter allergen expression with the
Figure 3 Effect of cAMP on allergen gene expression. Relative expression levels on AMM + 1% glucose are shown; 1 mM of dbtcAMP was
added to the growth medium and the expression profiles of 17 A. fumigatus allergen genes were assessed by qRT-PCR. The results were
normalised against the b-tubulin gene and compared to the expression of the same allergen genes in the medium lacking dbtcAMP. Expression
of 16/17 allergen genes (except Asp f 23) was repressed by the presence of dbtcAMP; +cAMP, expression level on AMM + 1% glucose + 1 mM
dbtcAMP; T, expression of the b-tubulin comparator. Error bars represent standard error of mean of biological replicates calculated using
GraphPad PRISM 4.0.
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exception of Asp f 12. Asp f 9 was repressed by macro-
phages at an MOI of 1:2000 at both 24 h and 48 h but
was not repressed at an MOI of 1:200 although a
repressive trend can be observed. Asp f 1 and -11 were
induced at 24 h with an MOI of 1:2000 but not affected
by presence of macrophages at 48 h or with a higher
MOI. Several trends in expression could be imagined
from detailed visual inspection of the data.
Discussion
An increase in incidence of allergy caused by various
biological and environmental stimuli has been observed
in recent years and A. fumigatus has been associated
with a wide spectrum of allergic disorders such as
ABPA, allergic asthma and SAFS [21,34]. In immuno-
competent patients fungal spores are effectively elimi-
nated by macrophages whereas neutrophils are
responsible for defence against hyphal fragments [35]. It
is hypothesised that regulation of allergen gene expres-
sion depends on the environment in which the fungus
grows. In this study, A. fumigatus allergen expression
was tested during fungal exposure to various in vitro sti-
muli, similar to those encountered in the lung as well as
during fungal challenge with human immune cells. The
experiments presented here show a remarkable coordi-
nation of allergen expression in response to growth in
the presence of hydrogen peroxide, implying that a sin-
gle biological stimulus may play a role in gene regula-
tion. Oxidative stress caused by hydrogen peroxide has
been shown to strongly induce and dbtcAMP to
strongly repress expression of most allergen genes (16/
17 for both cases). The up-regulation of allergen genes
caused by hydrogen peroxide is consistent with the
hypothesis that allergen expression is induced during
the release of oxidative agents by macrophages and neu-
trophils during killing of conidia [35]. This should be
especially true for genes coding for proteins, which are
involved in conversion of toxic oxidative agents to less
toxic compounds, such as Asp f 3 (peroxiredoxin). How-
ever, the qRT-PCR data showed that the expression of
this gene is only slightly increased by hydrogen perox-
ide. This may suggest that other mechanisms involved
in eliminating peroxide may play a role such as for
example activation of genes coding for catalases or glu-
tathione peroxidases, which convert hydrogen peroxide
to water [36]. Similar results of limited expression of
Figure 4 Expression levels of allergen genes during co-culture with macrophages. Aspergillus was co-cultured with macrophages at two
different MOI - 1:200 and 1:2000 spores/macrophage for 48 h. RNA was extracted after 24 h and 48 h and qRT-PCR was used to determine
allergen expression levels. Expression levels were calculated for Aspergillus exposed to macrophages (+M) and Aspergillus only samples for both
time points. Expression levels are given as units relative to the comparator, b-tubulin (T) and this is shown for each gene tested to give an
indication of level of expression. Error bars represent standard error of mean of biological replicates calculated using GraphPad PRISM 4.0.
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Asp f 3 were also observed during A. fumigatus chal-
lenge with human immune cells, however it was depen-
dent on time of incubation and spore concentration
used. Since macrophages are able to eliminate spores
but not hyphae and because this protein has been loca-
lised in germinating spores [37], it is possible that acti-
vation of the gene responsible for production of this
allergen in hyphae is not as important as it is in spores.
However, the expression of allergen genes in conidia
was not tested because insufficient RNA concentrations
could be obtained. The expression of allergens in
response to an oxidative stress stimulus may be highly
significant in presentation of the proteins to the
immune system via antigen presenting cells such as
macrophages or dendritic cells.
It is also evident that exposure to dbtcAMP, which
has been shown to be involved in many regulatory pro-
cesses in various organisms [38], had an effect on
expression of A. fumigatus allergen genes. Sixteen out of
17 allergen genes were repressed upon addition of this
compound (except Asp f 23). Thus, coordinated regula-
tion of allergen gene expression by both cAMP and
hydrogen peroxide may suggest that there is a single
regulatory pathway, which might be particularly useful
in development of possible therapeutic agents in order
to control allergic responses.
Several other patterns of allergen gene expression have
been observed during in vitro experiments. Fungal pro-
teolytic allergens (Asp f 5, -10, -13 and -18) were highly
induced during growth in AMM + 1% glucose supple-
mented with hydrogen peroxide, however results
obtained from fungal challenge with human immune
cells showed that all of the protease coding genes were
highly repressed in such conditions. This confirms the
shift in allergen gene expression depending on environ-
mental conditions and suggests that proteases may not
be required for the fungus to survive in the presence if
macrophages. They might however be highly expressed
during growth with bronchial epithelial cells, which con-
tain high levels of protein structural components such
as tight junctions [39] or by exposure to mucus contain-
ing high level of mucin proteins [40].
The other conditions that most strongly affected gene
expression were menadione and anoxia (9/17 and 14/17
allergen genes repressed for these conditions, respec-
tively). Lipid moderately induced expression of 16/17
allergens and complete medium (SB) repressed 12/17
allergen genes tested. It is also evident that the allergen
gene expression depends on time of incubation and fun-
gal spore concentration present in the environment.
This was confirmed during fungal challenge with macro-
phages, in which the expression of 11/18 genes (Asp f 1-
4, -7, -8, -11, -12, -17, -22 and -23) at the higher MOI
(> 1:200) was induced after 24 h but decreased after 48
h of incubation. Since Asp f 1 is a ribotoxin and Asp f 3
is a peroxiredoxin, the up-regulation of genes coding for
these proteins was expected. Genes involved in protein
synthesis and folding, such as Asp f 8, 11 and 23 were
also induced during the first 24 h as expected. In con-
trast, lower MOI (> 1:2000) caused repression of several
allergen genes (Asp f 1, -8, -11 and -23) during the first
24 h of incubation but their induction after 48 h. This
suggests that the fungus might activate a putative
defence mechanism involving allergen proteins at an
early stage of invasion, reducing its gene expression
after the host defence mechanism is breached. The pro-
gress of conidial germination means that fewer spores
and more hyphae will be present in the medium at later
time points and because macrophages are only able to
eliminate spores [35], the nature of the stress perceived
by the fungus might be changed. Sugui and colleagues
[41] examined the expression of several conidial and
hyphal genes of A. fumigatus during exposure to neutro-
phils and found that the expression of most genes was
up-regulated in conidia but not in hyphae. It is therefore
possible that after challenge with macrophages, the
expression of some allergen genes is induced in conidia
and young germlings but not in mature hyphae or vice
versa. The AfYAP1 gene of A. fumigatus has been
shown to be involved in oxidative stress responses and
the proteomic analysis presented in this paper lists 28
proteins that are regulated including Asp f 3[42]. No
coordinate regulation of allergen genes was observed in
an transcriptome study of A. fumigatus in an immuno-
compromised mouse model[43].
The functions of the allergen proteins appear disparate
and include proteases, oxidative response proteins, ribo-
somal components and proteins of unknown role.
Therefore, existence of a coordinated expression profile
in response to any condition is rather unexpected. Since
allergen proteins must interact with the immune
machinery at some point in fungal colonization, com-
mensality, clearance or invasion their induction by
hydrogen peroxide and repression by cAMP might be
reasonably expected to be reflected in the interaction
with immune cells. That this assumption is overwhel-
mingly incorrect in the case of macrophages may be the
result of several factors. Firstly, the coordinated
responses observed in axenic culture may not be signifi-
cant in the interaction of fungus and the immune sys-
tem. However, this seems unlikely given the known
involvement of hydrogen peroxide in the early immune
response and its demonstrable role in fungal clearance
exemplified in chronic granulomatous disease. Secondly,
it is possible that macrophages are not important in this
respect and that other players in the immune response
such as neutrophils, eosinophils or dendritic cells are
more significant as sites of allergen induction. Finally we
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suspect that our co-cultivation experiment suffers from
lack of precise spatio-temporal localization of allergen
expression and that induction or repression is lost in
the averaging effect of large cell numbers, all at different
stages in the interaction. We suggest that this would
more profitably be studied on the basis of single cell-cell
interactions and we are currently examining this avenue
by use of GFP-allergen promoter and GFP-allergen pro-
tein fusion approaches. Interestingly examination of
microarray data from the closely related fungus A. nidu-
lans [30] suggests that orthologues of the allergen genes
in this fungus are not strongly induced in response to
hydrogen peroxide providing a possible explanation for
the absence of allergens in this organism.
The coordinated regulation and induction of allergen
expression is highly significant as it implies a possible
previously unsuspected characteristic of fungal allergen
proteins. The disparate allergen proteins may in fact be
part of a coordinated response to oxidative attack and
that there may be a possible therapeutic route towards
reducing or eliminating allergen expression during fun-
gal colonization via interference with sensing and signal
transduction of the oxidative stress response. Neverthe-
less, we note that many proteins are induced in
responses to oxidative stress and that relatively few of
these become allergens, therefore a role for structural
features or physical properties in advancement of a pro-
tein to allergenicity seems likely to remain an important
consideration.
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